Phase 1 trial and biomarker analysis of Buparlisib with weekly Cisplatin and Radiotherapy in high risk locally advanced squamous cell cancer of the Head and Neck.

Lorch JH, Wong K, Tishler RB, Haddad RI, O'Neill A, Shin KY, Liu M, Hanna GJ, Chau NG, Rabinowits G, Schoenfeld JD, Margalit DN, Goguen L, Uppaluri R, Thomas T, Kacew A, McHugh P, Harris E, Austin K, Huang J, Mahmood U, Kochupurakkal BS, Sholl LM, Spangle JM

Open source

DOI: 10.1158/1078-0432.ccr-21-3677
Published: 2026 Sep 9
Container: Clinical cancer research : an official journal of the American Association for Cancer Research
Publisher: Not recorded
Open access: no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1158/1078-0432.ccr-21-3677,
  title = {Phase 1 trial and biomarker analysis of Buparlisib with weekly Cisplatin and Radiotherapy in high risk locally advanced squamous cell cancer of the Head and Neck.},
  author = {Lorch JH and Wong K and Tishler RB and Haddad RI and O'Neill A and Shin KY and Liu M and Hanna GJ and Chau NG and Rabinowits G and Schoenfeld JD and Margalit DN and Goguen L and Uppaluri R and Thomas T and Kacew A and McHugh P and Harris E and Austin K and Huang J and Mahmood U and Kochupurakkal BS and Sholl LM and Spangle JM},
  year = {2026},
  journal = {Clinical cancer research : an official journal of the American Association for Cancer Research},
  doi = {10.1158/1078-0432.ccr-21-3677},
  url = {https://doi.org/10.1158/1078-0432.ccr-21-3677}
}

RIS

TY  - JOUR
TI  - Phase 1 trial and biomarker analysis of Buparlisib with weekly Cisplatin and Radiotherapy in high risk locally advanced squamous cell cancer of the Head and Neck.
AU  - Lorch JH
AU  - Wong K
AU  - Tishler RB
AU  - Haddad RI
AU  - O'Neill A
AU  - Shin KY
AU  - Liu M
AU  - Hanna GJ
AU  - Chau NG
AU  - Rabinowits G
AU  - Schoenfeld JD
AU  - Margalit DN
AU  - Goguen L
AU  - Uppaluri R
AU  - Thomas T
AU  - Kacew A
AU  - McHugh P
AU  - Harris E
AU  - Austin K
AU  - Huang J
AU  - Mahmood U
AU  - Kochupurakkal BS
AU  - Sholl LM
AU  - Spangle JM
PY  - 2026
JO  - Clinical cancer research : an official journal of the American Association for Cancer Research
DO  - 10.1158/1078-0432.ccr-21-3677
UR  - https://doi.org/10.1158/1078-0432.ccr-21-3677
ER  -

APA

JH, L., K, W., RB, T., RI, H., A, O., KY, S., M, L., GJ, H., NG, C., G, R., JD, S., DN, M., L, G., R, U., T, T., A, K., P, M., E, H., K, A., J, H., U, M., BS, K., LM, S., & JM, S. (2026). Phase 1 trial and biomarker analysis of Buparlisib with weekly Cisplatin and Radiotherapy in high risk locally advanced squamous cell cancer of the Head and Neck.. Clinical cancer research : an official journal of the American Association for Cancer Research. https://doi.org/10.1158/1078-0432.ccr-21-3677

Source records

pubmed · retrieved 2026-09-26T18:56:55.407Z
europe-pmc · retrieved 2026-09-26T18:56:55.421Z